PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Pyrazines”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,099 records · Page 61Linked to original sources
PubMed2000

A solid-phase synthesis of N,N'-disubstituted ureas and Perhydroimidazo

An efficient method for trapping isocyanates, generated from the Curtius rearrangement, with resin-bound amines is reported. A commercially available carboxylic acid is treated with diphenylphosphoryl azide, followed by thermal rearrangement, cooling, and trapping in one pot. Cleavage from the resin gives an N, N'-disubstituted urea in excellent purity, as demonstrated with several heterocyclic and aliphatic carboxylic acids. Further utility is shown by preparing several novel perhydroimidazo[1,5-a]pyrazines.

Journal Article↗
PubMed2001

Enhancing reductive cleavage of aromatic carboxamides.

[reaction: see text] A set of aromatic and especially heteroaromatic N-benzyl carboxamides, derived from naphthalene, pyridine, pyrazine, and quinoline, and the corresponding tert-butyl acylcarbamates have been synthesized and studied by cyclic voltammetry with respect to facilitated reduction. The latter undergo regiospecific cleavage of their C(O)-N bonds under very mild reductive conditions with formation of Boc-protected (benzyl)amine in most cases in nearly quantitative yields. Examples of preparative cleavage by controlled potential electrolysis, activated aluminum, and NaBH(4) are given.

Journal Article↗
PubMed2002

Di-[1,10]-phenanthrolinyl diazines: a new family of bis-tridentate chelators.

A series of three bis-tridentate bridging ligands has been prepared in which two 1,10-phenanthroline units have been symmetrically appended to a central pyridazine, pyrimidine, or pyrazine ring. These ligands have been treated with [Ru(tpy-d(11))Cl(3)] to afford both mono- and bimetallic complexes that show very self-consistent NMR properties. [structure: see text]

Journal Article↗
PubMed2003

Barrenazine A and B; two new cytotoxic alkaloids from an unidentified tunicate.

[structure: see text] Two novel compounds, barrenazine A (1) and B (2), were isolated from an unidentified tunicate collected at Barren Islands, Madagascar. The two new compounds are of an unprecedented heterocyclic skeleton, namely 1,3,4,6,8,9-hexahydrodipyridino[3,4-b:3',4'-e]pyrazine. The structures of the two alkaloids were elucidated by interpretation of MS, COSY, HMQC, HMBC, NOESY, and (15)N-HMBC data. Barrenazine A exhibits mild cytotoxicity against LOVO-DOX colon carcinoma (with a GI(50) value of 0.9 g/mL)

Animals↗
PubMed2005

Revision of outcome and mechanism of a new multicomponent reaction.

[reaction: see text] A recently reported multicomponent reaction (MCR) produces pyrido[1,2-a]pyrazines and not the previously described 1H-imidazol-4-yl-pyridines. This different structure is proposed on the basis of a new mechanism of formation and the spectroscopic data.

Journal Article↗
PubMed2000

Outer-ring stereochemical modulation of cytotoxicity in cephalostatins.

[structure: see text] 20- and 25'-epimers of cephalostatin 7, prepared by directed unsymmetrical pyrazine synthesis, address outer-ring topographical and stability questions and intimate an oxacarbenium ion rationale for the role in bioactivity of the spiroketal (E/F, E'/F') rings of this class of antitumor agents.

Animals↗
PubMed2003

Augmentation of H2 photoproduction in Rhodopseudomonas palustris by N-heterocyclic aromatic compounds.

Increases of 23- (5.6 mmol acetylene reduced mg dry wt(-1)) and 16- (4 mmol acetylene reduced mg dry wt(-1)) fold in nitrogenase activity and 12- (671 microl H2 mg dry wt(-1) h(-1)) and 6- (349 microl mg dry wt(-1) h(-1)) fold in H2 photoproduction in Rhodopseudomonas palustris JA1 over 24 h were achieved with pyrazine 2-carboxylate (3 mM) and 3-picoline (3 mM), respectively, and were higher than earlier reports of enhancement (1.5 to 5-fold) in biological H2 production using various alternative methods.

Acetylene↗
PubMed2004

Endogenous free fatty acids repel and attract Collembola.

We used video recording of the movement pattern of Protaphorura armata (Collembola) to test whether its avoidance of the odor of dead conspecifics extends to related species. P. armata was repelled by the odor of dead individuals of Onychiurus scotarius and Onychiurus circulans, but not by live individuals. Free palmitic, oleic, and linoleic acids were present in extracts of the three repellent species, but only free palmitic acid was detected in extracts of a fourth nonrepellent species, Folsomia candida. Synthetic palmitic acid was attractive to P. armata, linoleic acid was repellent, and oleic acid gave no response. o. scotarius and O. circulans also contained 2,3-dimethoxy-pyrido[2,3-b]pyrazine, known as a defense substance. We discuss the role of free fatty acids in predator avoidance, conspecifics attraction, and food recognition in P. armata.

Animals↗
PubMed2004

Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglias and mimics the action of amphetamine on in vitro rat striatal dopamine release.

Salviae miltiorrhizae Radix (SMR), an eminent herb in the treatment of cardiovascular disorder (called blood stasis in traditional Chinese medicine), is widely used in China, Japan, Taiwan and Korea. SMR is also herbal medicines used in the treatment of drug addiction without scientific support for their mechanism of action. We evaluated the effect of SMR on superoxide production by rat microglias using a 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one-dependent chemiluminescence assay. SMR dose-dependently inhibited superoxide production by microglias stimulated with phorbol myristate acetate or opsonized zymosan, while it had no effect on superoxide production by a hypoxanthinexanthine oxidase system. These results indicate that SMR does not have a scavenging effect, but has an inhibitory effect on superoxide generation by microglias. Although SMR is commonly used for treating chronic cerebral infarction, it may also have a protective effect on progression of Parkinson's disease or Alzheimer's disease. On the other hand, the present study investigated the effect of the medicinal plant on dopaminergic neurotransmission in comparison with amphetamine. The effect of crude water extracts (0.1 g/ml) of SMR on K+ (20 mM)-stimulated dopamine release from rat striatal slices was compared with amphetamine (10(-4) M) using high-performance liquid chromatography with electrochemical detection to measure endogenous dopamine. Amphetamine and SMR significantly increased K+-stimulated dopamine release (P<0.001) from rat striatal slices when compared with K+-stimulated alone. SMR potentiated the effect of amphetamine on K+-stimulated dopamine release (P<0.001) when compared with amphetamine alone. The results indicate that SMR may stimulate dopamine release in the same manner as amphetamine. It remains to be determined whether the effect of this extract on dopamine function is important in its therapeutic use in the treatment of drug addiction.

Amphetamine↗
PubMed1990

Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.

Pyrazinamide, the pyrazine analogue of nicotinamide, has been evaluated for its ability to modify the radiation response of hypoxic cells both in vivo and in vitro. Results obtained with three different murine tumour systems EMT6, LLC and SCCVII showed that pyrazinamide at a dose of 0.5 mg g-1 i.p. resulted in enhanced radiation response. Dose modification factors of between 1.3 and 1.6 were observed using in vivo/in vitro clonogenic assays. This enhancement was greater than that obtained in mouse intestine using crypt cell survival as an endpoint (DMF 1.1). In contrast to the tumour data in vivo, the in vitro results indicate that pyrazinamide displays little radiosensitising or toxic properties towards hypoxic CHO cells in culture. These results suggest that pyrazinamide exerts its effects in vivo either by directly perturbing tumour physiology or by being converted to an active metabolite. Blood flow studies performed using laser Doppler flowmetry indicate that pyrazinamide produces a small (32%) increase in overall tumour blood flow in the SCCVII tumour. Based on this finding, additional studies on tumour perfusion at the microregional level were performed in the SCCVII tumour using a histological technique involving injection of fluorescent stains which demarcate functional vasculature. The data show that when compared to saline injected controls, pyrazinamide reduced the number of vessels opening and closing over a 20 min period from 10.2% to 3.8%. This finding suggests that pyrazinamide may exert its effects at least in part by reducing the occurrence of acute hypoxia resulting from dynamic changes in microregional perfusion.

Animals↗
PubMed2003

Synthesis, biological evaluation and DNA binding properties of novel mono and bisnaphthalimides.

A novel series of mono and bisnaphthalimides was synthesized and their antiproliferative activities were evaluated against three tumor cell lines. Bisnaphthalimides 3 and 4, bearing a pyrazine ring fused to the naphthalimide system, showed activities in the order of 10(-8) microM, similar to elinafide. DNA binding properties and the ability to induce DNA damage were studied for some of the most active compounds.

Antineoplastic Agents↗
PubMed2004

Anionic carbonato and oxalato cobalt(III) nitrogen mustard complexes.

Synthetic approaches to cobalt(III) complexes [Co(L)(L')2] containing the bidentate dialkylating nitrogen mustard N,N-bis(2-chloroethyl)-1,2-ethanediamine (L = dce) together with anionic ancilliary ligands (L') which are either carbonato (CO3(2-)), oxalato (ox2-), bis(2-hydroxyethyl)dithiocarbamato (bhedtc-), 2-pyridine carboxylato (pico-) or 2-pyrazine carboxylato (pyzc-) were investigated. Synthetic routes were developed using the related amines N,N-diethyl-1,2-ethanediamine (dee) and 1,2-ethanediamine (en). The complexes [Co(CO3)2(L)]- (L = dee 1, dce 2), [Co(ox)2(L)]- (L = dee 3, dce 4), [Co(bhedtc)2(dee)]+ 5, [Co(bhedtc)2(en)]+ 6, mer-[Co(pico)3], mer-[Co(pyzc)]3 7 and [Co(pico)2(dee)]+ 8 were prepared and were characterised by IR, UV-Vis, 1H and 13C[1H] NMR spectroscopy, mass spectrometry and cyclic voltammetry. [Co(bhedtc)2(en)]BPh4 6b and trans(O)-[Co(pico)2(dee)]ClO4 8 were characterised by X-ray crystallography. In vitro biological tests were carried out on complexes 1-4 in order to assess the degree to which coordination of the mustard to cobalt attenuated its cytotoxicity, and the differential toxicity in air vs. nitrogen.

Animals↗
PubMed2003

Electronic properties of Ru(II) complexes bound to a bisphenolate bridge with low lying pi* orbitals.

The synthesis and a detailed investigation into the electronic properties of mononuclear and dinuclear Ru(II) complexes of the ligand bis(2-hydroxyphenyl)-2,5-dihydropyrazine (H(2)BHD) is described. In these complexes the Ru(II) moieties are bound through O,N coordination to an anionic phenolate and the pyrazine bridge. Relatively few reports are available on the dinuclear complexes bridged across a phenolate and this study provides an opportunity to examine the impact of reduced oxygen donor ligands on metal-metal communication. The results presented here reveal some very unusual behavior whereby the apparent location of the LUMO changes between the mononuclear and dinuclear complexes. The lowest energy optical transition appears to involve the peripheral bipyridine ligand as acceptor in the mononuclear complex, whereas this ligand is not involved in the lowest energy optical transition in the dinuclear complex. The origin of this difference is not clear, however, significant changes in the electronic properties of the mononuclear complex are observed on coordination of the second metal, reflected in significant alterations in the electrochemistry of the bridge and metals as well as changes in the optical spectroscopy. The BHD(2-) bridge is shown to support weakly coupled class II behavior according to the Robin and Day classification, reflected in a K(c) of 335.

Journal Article↗
PubMed2004

Tandem oxidation processes for the preparation of nitrogen-containing heteroaromatic and heterocyclic compounds.

alpha-hydroxy ketones undergo manganese dioxide-mediated oxidation followed by in situ trapping with aromatic or aliphatic 1,2-diamines to give quinoxalines or dihydropyrazines, respectively, in a one-pot procedure which avoids the need to isolate the highly reactive dicarbonyl intermediates. The scope and limitations of these procedures are outlined and modifications to this procedure are discussed in which reduction is carried out in the same reaction vessel, generating piperazines, or oxidation, leading to pyrazines.

Journal Article↗
PubMed2004

New pyridine carboxamide ligands and their complexation to copper(II). X-Ray crystal structures of mono-, di, tri- and tetranuclear copper complexes.

Seven new pyridine dicarboxamide ligands H2L(1-7) have been synthesised from condensation reactions involving pyridine-2,6-dicarboxylic acid (H2dipic), pyridine-2,6-dicarbonyl dichloride or 2,6-diaminopyridine with heterocyclic amine or carboxylic acid precursors. Crystallographic analyses of N,N'-bis(2-pyridyl)pyridine-2,6-dicarboxamide monohydrate (H2L8 x H2O), N,N'-bis[2-(2-pyridyl)methyl]pyridine-2,6-dicarboxamide and N,N'-bis[2-(2-pyridyl)ethyl]pyridine-2,6-dicarboxamide monohydrate revealed extensive intramolecular hydrogen bonding interactions. 2,6-Bis(pyrazine-2-carboxamido)pyridine (H2L6) and 2,6-bis(pyridine-2-carboxamido)pyridine (H2L7) reacted with copper(II) acetate monohydrate to give tricopper(II) complexes [Cu3(L)2(mu2-OAc)2]. X-Ray crystallography confirmed deprotonation of the amidic nitrogen atoms and that the (L6,7)2- ligands and acetate anions hold three copper(II) ions in approximately linear fashion. H2L8. Reacted with copper(II) tetrakis(pyridine) perchlorate to give [Cu(L8)(OH2)]2 x 2H2O, in which (L8)2- was tridentate through the nitrogen atoms of the central pyridine ring and the deprotonated carboxamide groups at one copper centre, with one of the terminal pyridyl rings coordinating to the other copper atom in the dimer. The corresponding reaction using H2L7 gave [Cu3(L7)2(py)2][ClO4]2, which transformed during an attempted recrystallisation from ethanol under aerobic conditions to a tetracopper(II) complex [Cu4(L7)2(L7-O)2].

Journal Article↗
PubMed2004

Various forms of linear dipyridyls in discrete rectangles, dinuclear rods, and one-dimensional networks containing (eta5-pentamethylcyclopentadienyl)rhodium(III).

[Cp*Rh(eta1-NO3)(eta2-NO3)] (1) reacted with pyrazine (pyz) to give a dinuclear complex [Cp*Rh(eta1-NO3)(mu-pyz)(0.5)]2.CH2Cl2(3.CH2Cl2). Tetranuclear rectangles of the type [Cp*Rh(eta1,mu-X)(mu-L)(0.5)]4(OTf)4(4a: X = N3, L = bpy; 4b: X = N3, L = bpe; 4c: X = NCO, L = bpy) were prepared from [Cp*Rh(H2O)3](OTf)2 (2), a pseudo-halide (Me3SiN3 or Me3SiNCO), and a linear dipyridyl [4,4'-bipyridine (bpy) or trans-1,2-bis(4-pyridyl)ethylene (bpe)] by self-assembly through one-pot synthesis at room temperature. Treating complex with NH4SCN and dipyridyl led to the formation of dinuclear rods, [Cp*Rh(eta1-SCN)3]2(LH2) (5a: L = bpy; 5b: L = bpe), in which two Cp*Rh(eta1-SCN)3 units are connected by the diprotonated dipyridyl (LH2(2+)) through N(+)-H...N hydrogen bonds. Reactions of complex 2 with 1-(trimethylsilyl)imidazole (TMSIm) and dipyridyl (bpy or bpe) also produced another family of dinuclear rods [Cp*Rh(ImH)3]2.L (6a: L = bpy; 6b: L = bpe). Treating 1 and 2 with TMSIm and NH4SCN (in the absence of dipyridyl) generated a 1-D chain [Cp*Rh(ImH)3](NO3)2 (7) and a 1-D helix [Cp*Rh(eta1-SCN)2(eta1-SHCN)].H2O (8.H2O), respectively. The structures of complexes 3.CH2Cl2, 4a.H2O, 4c.2H2O, 5b, 6a, 7 and 8.H2O were determined by X-ray diffraction.

Journal Article↗